Johnson & Johnson

(IN BRIEF) ViiV Healthcare has received approval from China’s National Medical Products Administration (NMPA) for Vocabria (cabotegravir) in combination with Rekambys (rilpivirine), marking the first complete long-acting HIV-1 injectable treatment in China. This approval allows people living with HIV in … Read the full press release →

(IN BRIEF) Sanofi has entered into an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, to develop and commercialize a vaccine candidate for extraintestinal pathogenic E. coli (ExPEC) that is currently in Phase 3 of clinical trials. ExPEC … Read the full press release →

(IN BRIEF) Barry Callebaut Group, the world’s leading manufacturer of high-quality chocolate and cocoa products, has appointed Peter Feld as its new Chief Executive Officer, effective immediately. Feld succeeds Peter Boone, who is stepping down for personal reasons. Feld has … Read the full press release →